Jeil-Kirin renames itself Kyowa Hakko Kirin Korea

Published: 2012-05-31 06:56:00

Updated: 2012-05-31 06:56:00

Jeil-Kirin Pharma plans to change its English corporate name to Kyowa Hakko Kirin Korea from June 1 in a bid to make tremendous strides across key scientific fields, including oncology, immunology and nephrology.

Jeil-Kirin’s leading products include A2 Grasin (filgrastim), Nesp (darbepoetin-α), Regpara (cinacalcet HCl), Renagel (sevelamer HCl), Busulfex (busulfan), MMC (mitomycin-C) and LUN...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.